Vaginal Nanoparticles
Vaginal Nanoparticles is a nanoscale drug delivery system specifically engineered for vaginal administration, distinguished by its ability to enhance localized or systemic therapeutic efficacy through controlled release, improved mucosal permeability, and targeted delivery within the vaginal mucosa.
54
Publications
2.7K
Citations
341
Authors
126
Institutions
Publications per year
2017–2026
31
Parents
54
Humberto H. Lara, Liliana Ixtepan-Turrent, Elsa N. Garza-Treviño et al. · Journal of Nanobiotechnology · 2010 · 181 citations · Full text
Cytolytic Nanoparticles Attenuate HIV-1 Infectivity
Joshua L. Hood, Andrew Jallouk, Nancy Campbell et al. · Antiviral Therapy · 2012 · 119 citations
Haitao Yang, Jing Li, Sravan Kumar Patel et al. · Pharmaceutics · 2019 · 98 citations · Full text
1–5 of 54
341
3
h-index
3
h-index
3
h-index
2
h-index
2
h-index
1–5 of 341
126

Johns Hopkins University
Baltimore, United States
3 h-index
28 publications
4.7K citations
Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde
Gandra, Portugal
3 h-index
9 publications
758 citations
Cooperativa de Ensino Superior Politécnico e Universitário
Gandra, Portugal
3 h-index
9 publications
758 citations

Universidade do Porto
Porto, Portugal
3 h-index
12 publications
1.1K citations
Union Hospital
Shatin, China
2 h-index
3 publications
54 citations

University of Manitoba
Winnipeg, Canada
2 h-index
6 publications
300 citations
Eskişehir City Hospital
Eskişehir, Turkey
2 h-index
8 publications
369 citations

Anadolu University
Eskişehir, Türkiye
2 h-index
8 publications
369 citations
1–8 of 126
4 publications · 106 citations
4
h-index
3 publications · 93 citations
3
h-index
2 publications · 177 citations
2
h-index
1 publications · 34 citations
2
h-index
2 publications · 58 citations
2
h-index
1–5